journal article·2022-02Open access

Nanoengineering Palladium Plasmonic Nanosheets Inside Polymer Nanospheres for Photothermal Therapy and Targeted Drug Delivery

Laura Uson, Cristina Yus, Gracia Mendoza, Eric Leroy, Silvia Irusta, Teresa Alejo, David García‐Domingo, Ane Larrea, Manuel Arruebo, Raul Arenal, Victor Sebastian

Advanced Functional Materials· Volume 32· Issue 9

Abstract

Abstract The incorporation of plasmonic nanoconstructs in biodegradable polymeric nanoparticles (NPs), together with therapeutic drugs in a controlled procedure is of interest for different applications in Nanomedicine. Advanced hybrid nanomaterials can be engineered by combining the in situ formation of plasmonic palladium nanosheets (NSs) and the proper ionic nature of the encapsulated drug. This study presents a new procedure to synthesize hybrid nanostructures by a Pickering double emulsion. Anisotropic palladium (Pd) NSs with unique near‐infrared (NIR)‐optical properties can be assembled within a poly lactic‐co‐glycolic acid matrix of < 200 nm NPs, when Pd precursors are in situ reduced via a gas‐phase procedure. The hybrid nanomaterials respond to external NIR light stimulus. The unprecedented precision to assemble, in a single stage, plasmonic nanoconstructs having a total loading selectivity, when encapsulated in combination with hydrophobic drugs, offers new opportunities in the new class of theragnostics, in particular when triggered drug delivery and photothermal therapies are required.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Pickering emulsions and particle stabilization · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Nanociencia y Materiales de Aragón (INMA) CSIC‐Universidad de Zaragoza Zaragoza 50009 Spain

Department of Chemical Engineering University of Zaragoza Campus Río Ebro‐Edificio I+D C/ Poeta Mariano Esquillor S/N Zaragoza 50018 Spain

Networking Research Center on Bioengineering Biomaterials and Nanomedicine CIBER‐BBN Madrid 28029 Spain

Aragon Health Research Institute (IIS Aragón) Zaragoza 50009 Spain

Université Paris‐Est Institut de Chimie et des Matériaux Paris‐Est UMR 7182 CNRS – UPEC 2 Rue H. Dunant Thiais 94320 France

Laboratorio de Microscopías Avanzadas Universidad de Zaragoza Zaragoza 50018 Spain

ARAID Foundation Zaragoza 50018 Spain

Funding

European Research Council

References (89)

Show source-provided references
1. 10.3390/nano1007140310.3390/nano10071403 ↗
2. 10.1016/j.addr.2012.08.01210.1016/j.addr.2012.08.012 ↗
3. 10.1016/j.dyepig.2018.05.03210.1016/j.dyepig.2018.05.032 ↗
4. 10.1080/10717544.2016.126138110.1080/10717544.2016.1261381 ↗
5. 10.1016/j.ccr.2013.04.02210.1016/j.ccr.2013.04.022 ↗
6. 10.1016/B978-0-08-100092-2.00002-310.1016/B978-0-08-100092-2.00002-3 ↗
7. 10.1016/j.ijpharm.2019.03.01110.1016/j.ijpharm.2019.03.011 ↗
8. 10.1016/j.cis.2017.04.00810.1016/j.cis.2017.04.008 ↗
9. 10.1021/ar600012y10.1021/ar600012y ↗
10. 10.1080/21691401.2019.160453510.1080/21691401.2019.1604535 ↗
11. 10.1016/j.eurpolymj.2019.02.00710.1016/j.eurpolymj.2019.02.007 ↗
12. 10.2147/IJN.S10881210.2147/IJN.S108812 ↗
13. 10.1039/C6RA23620K10.1039/C6RA23620K ↗
14. 10.1016/j.colsurfb.2017.07.03810.1016/j.colsurfb.2017.07.038 ↗
15. 10.1016/j.jconrel.2012.01.04310.1016/j.jconrel.2012.01.043 ↗
16. 10.3390/polym303137710.3390/polym3031377 ↗
17. 10.2147/IJN.S10881210.2147/IJN.S108812 ↗
18. 10.1002/adma.20120065310.1002/adma.201200653 ↗
19. 10.1002/adfm.20170162610.1002/adfm.201701626 ↗
20. 10.1016/j.ejpb.2019.10.00410.1016/j.ejpb.2019.10.004 ↗
21. 10.1016/j.jcis.2018.03.10710.1016/j.jcis.2018.03.107 ↗
22. 10.1016/j.progpolymsci.2014.07.00510.1016/j.progpolymsci.2014.07.005 ↗
23. 10.1039/C5NR06850A10.1039/C5NR06850A ↗
24. 10.1039/c3nr04013e10.1039/c3nr04013e ↗
25. 10.1016/j.cej.2017.02.00310.1016/j.cej.2017.02.003 ↗
26. 10.1016/j.jddst.2017.04.00810.1016/j.jddst.2017.04.008 ↗
27. 10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
28. 10.1016/B978-0-12-813928-8.09997-X10.1016/B978-0-12-813928-8.09997-X ↗
29. 10.1016/j.mtcomm.2018.04.01210.1016/j.mtcomm.2018.04.012 ↗
30. 10.1021/ar800150g10.1021/ar800150g ↗
31. 10.1016/j.jcis.2018.08.06910.1016/j.jcis.2018.08.069 ↗
32. 10.1002/bdrb.2015010.1002/bdrb.20150 ↗
33. 10.1038/nbt.169610.1038/nbt.1696 ↗
34. 10.1039/C8TA03557A10.1039/C8TA03557A ↗
35. 10.1038/s41929-019-0333-410.1038/s41929-019-0333-4 ↗
36. 10.1021/acsami.7b1728210.1021/acsami.7b17282 ↗
37. 10.1002/smll.20130363110.1002/smll.201303631 ↗
38. 10.1007/s10118-019-2193-410.1007/s10118-019-2193-4 ↗
39. 10.1002/1520-6017(200012)89:12<1558::AID-JPS6>3.0.CO;2-810.1002/1520-6017(200012)89:12<1558::AID-JPS6>3.0.CO;2-8 ↗
40. 10.1016/B978-0-08-101995-5.00008-810.1016/B978-0-08-101995-5.00008-8 ↗
41. 10.1016/j.jconrel.2015.07.01810.1016/j.jconrel.2015.07.018 ↗
42. 10.1002/wnan.140810.1002/wnan.1408 ↗
43. 10.1038/8668410.1038/86684 ↗
44. 10.1016/j.jconrel.2018.12.02910.1016/j.jconrel.2018.12.029 ↗
45. 10.1016/j.ijpharm.2007.10.00410.1016/j.ijpharm.2007.10.004 ↗
46. 10.1016/j.jiec.2019.02.02810.1016/j.jiec.2019.02.028 ↗
47. 10.1038/nnano.2010.23510.1038/nnano.2010.235 ↗
48. 10.1039/C5NR08531D10.1039/C5NR08531D ↗
49. 10.1002/smll.20080154610.1002/smll.200801546 ↗
50. 10.1039/C7NR03365F10.1039/C7NR03365F ↗
51. 10.1039/C6NR08763A10.1039/C6NR08763A ↗
52. 10.1016/j.msec.2017.12.03610.1016/j.msec.2017.12.036 ↗
53. 10.2217/nnm-2018-025810.2217/nnm-2018-0258 ↗
54. 10.2174/092986652166614080711424010.2174/0929866521666140807114240 ↗
55. a)S. J.Pennycook P. D.Nellist Springer New York2011;
56. 10.1021/nl501645g10.1021/nl501645g ↗
57. 10.1016/j.colsurfb.2020.11090410.1016/j.colsurfb.2020.110904 ↗
58. 10.1016/j.matlet.2012.10.12910.1016/j.matlet.2012.10.129 ↗
59. 10.1016/S0939-6411(03)00193-010.1016/S0939-6411(03)00193-0 ↗
60. 10.1016/j.jconrel.2016.06.01710.1016/j.jconrel.2016.06.017 ↗
61. 10.1016/j.jpba.2009.11.01310.1016/j.jpba.2009.11.013 ↗
62. 10.1016/j.ijpx.2019.10003010.1016/j.ijpx.2019.100030 ↗
63. 10.1016/j.biopha.2017.01.17510.1016/j.biopha.2017.01.175 ↗
64. 10.1016/j.ejpb.2007.02.01610.1016/j.ejpb.2007.02.016 ↗
65. B. P. National Center for Biotechnology Information."PubChem Compound Summary for CID 2474 https://pubchem.ncbi.nlm.nih.gov/compound/Bupivacaine(accessed: October2020).
66. 10.1038/ncomms1428110.1038/ncomms14281 ↗
67. 10.1021/la011420k10.1021/la011420k ↗
68. 10.1002/macp.20190019610.1002/macp.201900196 ↗
69. 10.1002/smll.20080185510.1002/smll.200801855 ↗
70. 10.1023/A:101623842731310.1023/A:1016238427313 ↗
71. 10.1016/j.ijbiomac.2019.12.19310.1016/j.ijbiomac.2019.12.193 ↗
72. 10.1088/1742-6596/1295/1/01206310.1088/1742-6596/1295/1/012063 ↗
73. 10.1002/pi.169710.1002/pi.1697 ↗
74. 10.1016/j.jconrel.2018.07.04410.1016/j.jconrel.2018.07.044 ↗
75. 10.1016/S0378-5173(03)00379-X10.1016/S0378-5173(03)00379-X ↗
76. 10.1021/acs.chemrev.5b0034610.1021/acs.chemrev.5b00346 ↗
77. 10.1016/j.reactfunctpolym.2019.10444910.1016/j.reactfunctpolym.2019.104449 ↗
78. ISO 10993–5:2009http://www.iso.org/iso/catalogue_detail.htm?csnumber=36406(accessed: October2020).
79. 10.1039/D0NJ00580K10.1039/D0NJ00580K ↗
80. 10.1038/ncomms1590610.1038/ncomms15906 ↗
81. 10.1002/bit.2684510.1002/bit.26845 ↗
82. 10.1016/j.drudis.2012.10.00310.1016/j.drudis.2012.10.003 ↗
83. 10.1002/smll.20080178810.1002/smll.200801788 ↗
84. 10.1038/s41378-020-0167-x10.1038/s41378-020-0167-x ↗
85. 10.1080/10717544.2017.137731610.1080/10717544.2017.1377316 ↗
86. 10.1208/s12248-013-9478-210.1208/s12248-013-9478-2 ↗
87. 10.1021/nn301282m10.1021/nn301282m ↗
88. 10.1016/S0928-0987(03)00119-210.1016/S0928-0987(03)00119-2 ↗
89. 10.1523/JNEUROSCI.3578-14.201510.1523/JNEUROSCI.3578-14.2015 ↗